Posterior pole vascular changes before treatment of retinopathy of prematurity

S. Grace Prakalapakorn, David K. Wallace, Sharon F. Freedman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

IMPORTANCE Some proponents of telemedicine screening for retinopathy of prematurity (ROP) believe that a screening system based on the characteristics of posterior pole vessels is sufficient for identifying infants needing treatment. OBJECTIVE To evaluate the vascular characteristics present when treatment was determined to be needed and the number of days from the last examination when the vessels of both eyes were noted to be normal until a decision was made to treat. DESIGN, SETTING, AND PARTICIPANTS This retrospective study included all infants who underwent longitudinal examination and treatment for ROP in the neonatal intensive care unit at an academic medical center, Duke University, from June 22, 2013, through May 2, 2017. MAIN OUTCOMES AND MEASURES Vascular characteristics present on clinical examination when an infant was determined to need treatment and the number of days from the last examination when the vessels of both eyes were noted to be normal until a decision was made to treat. RESULTS Fifty-five infants (30 male and 25 female) met eligibility criteria, with a mean birthweight of 733 g (range, 420-1060 g), mean gestational age of 25.1 weeks (range, 22.9-27.7 weeks), and mean postmenstrual age when a decision was made to treat of 36.7 weeks (range, 31.4-43.0 weeks). When an infant was determined to need treatment, 51 (93%) had plus disease; 3 (5%), preplus disease; and 1 (2%), neither. The number of days from the last examination when an infant was noted to have normal vessels bilaterally until a decision was made to treat ranged from 0 to 49 days. The interval was at least 14 days for 42 infants (76%) and at least 7 days for all but 1 infant (98%). The exception was an infant with the rare scenario of neither preplus nor plus disease with zone I, stage 3 ROP (type 1 ROP) at the time when the examiner decided to treat. CONCLUSIONS AND RELEVANCE At the time when infants were determined to need treatment for ROP, all but 1 had preplus or plus disease. These results suggest that narrow-field imaging for ROP screening should include all of zone I to identify the rare treatment-requiring ROP with normal posterior pole vessels. If confirmed, with sufficient image quality, weekly photographic screening of zone I likely should capture changes indicative of impending ROP requiring treatment.

Original languageEnglish (US)
Pages (from-to)1430-1433
Number of pages4
JournalJAMA Ophthalmology
Volume135
Issue number12
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Retinopathy of Prematurity
Blood Vessels
Therapeutics
Telemedicine
Neonatal Intensive Care Units
Gestational Age
Retrospective Studies
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Posterior pole vascular changes before treatment of retinopathy of prematurity. / Prakalapakorn, S. Grace; Wallace, David K.; Freedman, Sharon F.

In: JAMA Ophthalmology, Vol. 135, No. 12, 01.12.2017, p. 1430-1433.

Research output: Contribution to journalArticle

Prakalapakorn, S. Grace ; Wallace, David K. ; Freedman, Sharon F. / Posterior pole vascular changes before treatment of retinopathy of prematurity. In: JAMA Ophthalmology. 2017 ; Vol. 135, No. 12. pp. 1430-1433.
@article{d8a30ce78a84407fb0b1c497a83492ce,
title = "Posterior pole vascular changes before treatment of retinopathy of prematurity",
abstract = "IMPORTANCE Some proponents of telemedicine screening for retinopathy of prematurity (ROP) believe that a screening system based on the characteristics of posterior pole vessels is sufficient for identifying infants needing treatment. OBJECTIVE To evaluate the vascular characteristics present when treatment was determined to be needed and the number of days from the last examination when the vessels of both eyes were noted to be normal until a decision was made to treat. DESIGN, SETTING, AND PARTICIPANTS This retrospective study included all infants who underwent longitudinal examination and treatment for ROP in the neonatal intensive care unit at an academic medical center, Duke University, from June 22, 2013, through May 2, 2017. MAIN OUTCOMES AND MEASURES Vascular characteristics present on clinical examination when an infant was determined to need treatment and the number of days from the last examination when the vessels of both eyes were noted to be normal until a decision was made to treat. RESULTS Fifty-five infants (30 male and 25 female) met eligibility criteria, with a mean birthweight of 733 g (range, 420-1060 g), mean gestational age of 25.1 weeks (range, 22.9-27.7 weeks), and mean postmenstrual age when a decision was made to treat of 36.7 weeks (range, 31.4-43.0 weeks). When an infant was determined to need treatment, 51 (93{\%}) had plus disease; 3 (5{\%}), preplus disease; and 1 (2{\%}), neither. The number of days from the last examination when an infant was noted to have normal vessels bilaterally until a decision was made to treat ranged from 0 to 49 days. The interval was at least 14 days for 42 infants (76{\%}) and at least 7 days for all but 1 infant (98{\%}). The exception was an infant with the rare scenario of neither preplus nor plus disease with zone I, stage 3 ROP (type 1 ROP) at the time when the examiner decided to treat. CONCLUSIONS AND RELEVANCE At the time when infants were determined to need treatment for ROP, all but 1 had preplus or plus disease. These results suggest that narrow-field imaging for ROP screening should include all of zone I to identify the rare treatment-requiring ROP with normal posterior pole vessels. If confirmed, with sufficient image quality, weekly photographic screening of zone I likely should capture changes indicative of impending ROP requiring treatment.",
author = "Prakalapakorn, {S. Grace} and Wallace, {David K.} and Freedman, {Sharon F.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1001/jamaophthalmol.2017.4608",
language = "English (US)",
volume = "135",
pages = "1430--1433",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Posterior pole vascular changes before treatment of retinopathy of prematurity

AU - Prakalapakorn, S. Grace

AU - Wallace, David K.

AU - Freedman, Sharon F.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - IMPORTANCE Some proponents of telemedicine screening for retinopathy of prematurity (ROP) believe that a screening system based on the characteristics of posterior pole vessels is sufficient for identifying infants needing treatment. OBJECTIVE To evaluate the vascular characteristics present when treatment was determined to be needed and the number of days from the last examination when the vessels of both eyes were noted to be normal until a decision was made to treat. DESIGN, SETTING, AND PARTICIPANTS This retrospective study included all infants who underwent longitudinal examination and treatment for ROP in the neonatal intensive care unit at an academic medical center, Duke University, from June 22, 2013, through May 2, 2017. MAIN OUTCOMES AND MEASURES Vascular characteristics present on clinical examination when an infant was determined to need treatment and the number of days from the last examination when the vessels of both eyes were noted to be normal until a decision was made to treat. RESULTS Fifty-five infants (30 male and 25 female) met eligibility criteria, with a mean birthweight of 733 g (range, 420-1060 g), mean gestational age of 25.1 weeks (range, 22.9-27.7 weeks), and mean postmenstrual age when a decision was made to treat of 36.7 weeks (range, 31.4-43.0 weeks). When an infant was determined to need treatment, 51 (93%) had plus disease; 3 (5%), preplus disease; and 1 (2%), neither. The number of days from the last examination when an infant was noted to have normal vessels bilaterally until a decision was made to treat ranged from 0 to 49 days. The interval was at least 14 days for 42 infants (76%) and at least 7 days for all but 1 infant (98%). The exception was an infant with the rare scenario of neither preplus nor plus disease with zone I, stage 3 ROP (type 1 ROP) at the time when the examiner decided to treat. CONCLUSIONS AND RELEVANCE At the time when infants were determined to need treatment for ROP, all but 1 had preplus or plus disease. These results suggest that narrow-field imaging for ROP screening should include all of zone I to identify the rare treatment-requiring ROP with normal posterior pole vessels. If confirmed, with sufficient image quality, weekly photographic screening of zone I likely should capture changes indicative of impending ROP requiring treatment.

AB - IMPORTANCE Some proponents of telemedicine screening for retinopathy of prematurity (ROP) believe that a screening system based on the characteristics of posterior pole vessels is sufficient for identifying infants needing treatment. OBJECTIVE To evaluate the vascular characteristics present when treatment was determined to be needed and the number of days from the last examination when the vessels of both eyes were noted to be normal until a decision was made to treat. DESIGN, SETTING, AND PARTICIPANTS This retrospective study included all infants who underwent longitudinal examination and treatment for ROP in the neonatal intensive care unit at an academic medical center, Duke University, from June 22, 2013, through May 2, 2017. MAIN OUTCOMES AND MEASURES Vascular characteristics present on clinical examination when an infant was determined to need treatment and the number of days from the last examination when the vessels of both eyes were noted to be normal until a decision was made to treat. RESULTS Fifty-five infants (30 male and 25 female) met eligibility criteria, with a mean birthweight of 733 g (range, 420-1060 g), mean gestational age of 25.1 weeks (range, 22.9-27.7 weeks), and mean postmenstrual age when a decision was made to treat of 36.7 weeks (range, 31.4-43.0 weeks). When an infant was determined to need treatment, 51 (93%) had plus disease; 3 (5%), preplus disease; and 1 (2%), neither. The number of days from the last examination when an infant was noted to have normal vessels bilaterally until a decision was made to treat ranged from 0 to 49 days. The interval was at least 14 days for 42 infants (76%) and at least 7 days for all but 1 infant (98%). The exception was an infant with the rare scenario of neither preplus nor plus disease with zone I, stage 3 ROP (type 1 ROP) at the time when the examiner decided to treat. CONCLUSIONS AND RELEVANCE At the time when infants were determined to need treatment for ROP, all but 1 had preplus or plus disease. These results suggest that narrow-field imaging for ROP screening should include all of zone I to identify the rare treatment-requiring ROP with normal posterior pole vessels. If confirmed, with sufficient image quality, weekly photographic screening of zone I likely should capture changes indicative of impending ROP requiring treatment.

UR - http://www.scopus.com/inward/record.url?scp=85039939819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039939819&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2017.4608

DO - 10.1001/jamaophthalmol.2017.4608

M3 - Article

VL - 135

SP - 1430

EP - 1433

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 12

ER -